99mTc-HMDP scintigraphy rectifies wrong diagnosis of AL amyloidosis

Journal of Nuclear Cardiology

Volumn 22, Issue 4, 2015, Pages 853-857

  Galat, Arnault ^a,b,c,d,e   Van Der Gucht, Axel ^a,b,c,e   Colombat, Magali ^f,g   Attias, David ^h   Itti, Emmanuel ^a,b,c,e   Meignan, Michel ^a,b,c,e   Lebras, Fabien ^a,b,c,e   Molinier Frenkel, Valérie ^a,b,c,d   Benhaiem, Nicole ^a,b,c,e   Guellich, Aziz ^a,b,c,d,e   Rosso, Jean ^a,b,c,e   Damy, Thibaud ^a,b,c,d,e  

^a UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^b Mondor Amyloidosis Network   (France)

^c HENRI MONDOR HOSPITAL   (France)

^d INSERM U955   (France)

^e DHU ATVB   (France)

^f FOCH HOSPITAL   (France)

^g UNIVERSITÉ PARIS DESCARTES   (France)

^h CENTRE CARDIOLOGIQUE DU NORD   (France)

Author keywords

99mTc HMDP scintigraphy; cardiac amyloidosis; light chain immunoglobulin; protein deposition; transthyretin

Indexed keywords

BORTEZOMIB; CYCLOPHOSPHAMIDE; DEXAMETHASONE; GADOLINIUM; IMMUNOGLOBULIN LIGHT CHAIN; OXIDRONATE TECHNETIUM TC 99M; PREALBUMIN; MEDRONATE TECHNETIUM TC 99M; RADIOPHARMACEUTICAL AGENT; TECHNETIUM TC 99M (SN) HYDROXYMETHYLENE DIPHOSPHONATE;

AFRICAN; AGED; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CASE REPORT; CONTRAST ENHANCEMENT; DIAGNOSTIC ERROR; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; DRUG UPTAKE; GENE MUTATION; GENETIC DISORDER; HEART AMYLOIDOSIS; HEART FAILURE; HEART MUSCLE BIOPSY; HEART SCINTISCANNING; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MONOCLONAL IMMUNOGLOBULINEMIA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RESTRICTIVE CARDIOMYOPATHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; ANALOGS AND DERIVATIVES; CARDIOMYOPATHY; FAMILIAL AMYLOIDOSIS; GENETICS; PREVENTION AND CONTROL; SCINTISCANNING;

AGED; AMYLOIDOSIS, FAMILIAL; CARDIOMYOPATHIES; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC ERRORS; HUMANS; MALE; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M MEDRONATE;

EID: 84939271326     PISSN: 10713581     EISSN: 15326551     Source Type: Journal    
DOI: 10.1007/s12350-015-0176-6     Document Type: Article

References (7)

1. Glaudemans AWJM, van Rheenen RWJ, van den Berg MP, Noordzij W, Koole M, Blokzijl H, et al. Bone scintigraphy with (99m)technetium-hydroxymethylene diphosphonate allows early diagnosis of cardiac involvement in patients with transthyretin-derived systemic amyloidosis. Amyloid 2014;21:35-44.
2. Eriksson P, Backman C, Bjerle P, Eriksson A, Holm S, Olofsson BO. Non-invasive assessment of the presence and severity of cardiac amyloidosis. A study in familial amyloidosis with polyneuropathy by cross sectional echocardiography and technetium-99m pyrophosphate scintigraphy. Br Heart J 1984;52:321-6.
3. Worsley DF, Lentle BC. Uptake of technetium-99m MDP in primary amyloidosis with a review of the mechanisms of soft tissue localization of bone seeking radiopharmaceuticals. J Nucl Med 1993;34:1612-5.
4. Kulhanek J, Movahed A. Uptake of technetium 99m HDP in cardiac amyloidosis. Int J Cardiovasc Imaging 2003;19:225-7.
5. Rapezzi C, Quarta CC, Guidalotti PL, Pettinato C, Fanti S, Leone O, et al. Role of (99m)Tc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis. JACC Cardiovasc Imaging 2011;4:659-70.
6. Lee VW, Caldarone AG, Falk RH, Rubinow A, Cohen AS. Amyloidosis of heart and liver: Comparison of Tc-99m pyrophosphate and Tc-99m methylene diphosphonate for detection. Radiology 1983;148:239-42.
7. 99mTc-DPD in the differentiation of cardiac amyloidosis subtype. Rev Esp Cardiol 2012;65:440-6.